DeLong Mark Jeffrey
Chief Business & Strat Officer
CIK: 1856078
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 11, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | S | 368 | $22.15 | $8,152.56 | View Details Filing |
| Jan 28, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | A | 36,606 | $0.00 | $0.00 | View Details Filing |
| Jan 22, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | S | 3,371 | $21.77 | $73,371.16 | View Details Filing |
| Jan 20, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | S | 1,334 | $19.79 | $26,403.73 | View Details Filing |
| Jan 13, 2026 | Apellis Pharmaceuticals, Inc. (APLS) | S | 1,780 | $22.19 | $39,493.22 | View Details Filing |